Role of amyloid β protein receptors in mediating synaptic plasticity (Review)
- Authors:
- Yu Li
- Zhongqing Sun
- Qiaoyu Cao
- Meiwan Chen
- Huanmin Luo
- Xi Lin
- Fei Xiao
-
Affiliations: Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, P.R. China - Published online on: February 21, 2017 https://doi.org/10.3892/br.2017.863
- Pages: 379-386
This article is mentioned in:
Abstract
Brambilla D, Le Droumaguet B, Nicolas J, Hashemi SH, Wu LP, Moghimi SM, Couvreur P and Andrieux K: Nanotechnologies for Alzheimer's disease: Diagnosis, therapy, and safety issues. Nanomedicine. 7:521–540. 2011.PubMed/NCBI | |
Selkoe DJ and Hardy J: The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 8:595–608. 2016. View Article : Google Scholar : PubMed/NCBI | |
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y and LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron. 39:409–421. 2003. View Article : Google Scholar : PubMed/NCBI | |
Glenner GG and Wong CW: Alzheimer's disease: initial report of the purification ans characterization of a novel cerebrovascular amyloidprotein. Biochem Biophys Res Commun. 425:534–539. 2012. View Article : Google Scholar : PubMed/NCBI | |
Selkoe DJ: Alzheimer's disease is a synaptic failure. Science. 298:789–791. 2002. View Article : Google Scholar : PubMed/NCBI | |
Audrain M, Fol R, Dutar P, Potier B, Billard JM, Flament J, Alves S, Burlot MA, Dufayet-Chaffaud G, Bemelmans AP, et al: Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression. Mol Neurodegener. 11:52016. View Article : Google Scholar : PubMed/NCBI | |
Lacor PN: Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics. 8:486–508. 2007. View Article : Google Scholar : PubMed/NCBI | |
Terry RD: Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol. 59:1118–1119. 2000. View Article : Google Scholar : PubMed/NCBI | |
Scheff SW, Price DA, Schmitt FA, DeKosky ST and Mufson EJ: Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology. 68:1501–1508. 2007. View Article : Google Scholar : PubMed/NCBI | |
Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, et al: Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 103:5161–5166. 2006. View Article : Google Scholar : PubMed/NCBI | |
Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H, Lin MT, Tampellini D, Klann E, Blitzer RD and Gouras GK: Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS One. 5:e128452010. View Article : Google Scholar : PubMed/NCBI | |
Ma T and Klann E: Amyloid β: Linking synaptic plasticity failure to memory disruption in Alzheimer's disease. J Neurochem. 120 Suppl 1:140–148. 2012. View Article : Google Scholar : PubMed/NCBI | |
Malenka RC: The long-term potential of LTP. Nat Rev Neurosci. 4:923–926. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kandel ER: The molecular biology of memory storage: A dialog between genes and synapses. Biosci Rep. 21:565–611. 2001. View Article : Google Scholar : PubMed/NCBI | |
Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D and Ward PJ: Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248:1122–1124. 1990. View Article : Google Scholar : PubMed/NCBI | |
Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K and Müller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:733–736. 1987. View Article : Google Scholar : PubMed/NCBI | |
Selkoe DJ: The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8:447–453. 1998. View Article : Google Scholar : PubMed/NCBI | |
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, et al: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med. 14:837–842. 2008. View Article : Google Scholar : PubMed/NCBI | |
Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, Betts V, Podlisny MB, Cleary JP, Ashe KH, Rowan MJ, et al: The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem Soc Trans. 33:1087–1090. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hardy J and Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 297:353–356. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cheng X, Wu J, Geng M and Xiong J: Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease. Neurobiol Aging. 35:1217–1232. 2014. View Article : Google Scholar : PubMed/NCBI | |
Stéphan A and Phillips AG: A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav. 4:157–172. 2005. View Article : Google Scholar : PubMed/NCBI | |
Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M and Ashe KH: A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 440:352–357. 2006. View Article : Google Scholar : PubMed/NCBI | |
Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ and Ashe KH: Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci. 8:79–84. 2005. View Article : Google Scholar : PubMed/NCBI | |
Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ and Sabatini BL: Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 27:2866–2875. 2007. View Article : Google Scholar : PubMed/NCBI | |
Selkoe DJ: Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res. 192:106–113. 2008. View Article : Google Scholar : PubMed/NCBI | |
Townsend M, Shankar GM, Mehta T, Walsh DM and Selkoe DJ: Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers. J Physiol. 572:477–492. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S and Malinow R: AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron. 52:831–843. 2006. View Article : Google Scholar : PubMed/NCBI | |
Hanson JE, Pare JF, Deng L, Smith Y and Zhou Q: Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease. Neurobiol Dis. 74:254–262. 2015. View Article : Google Scholar : PubMed/NCBI | |
Jarosz-Griffiths HH, Noble E, Rushworth JV and Hooper NM: Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. J Biol Chem. 291:3174–3183. 2016. View Article : Google Scholar : PubMed/NCBI | |
Xia M, Cheng X, Yi R, Gao D and Xiong J: The Binding Receptors of Aβ: An Alternative Therapeutic Target for Alzheimer's Disease. Mol Neurobiol. 53:455–471. 2016. View Article : Google Scholar : PubMed/NCBI | |
Carrell RW and Gooptu B: Conformational changes and disease - serpins, prions and Alzheimer's. Curr Opin Struct Biol. 8:799–809. 1998. View Article : Google Scholar : PubMed/NCBI | |
Caiati MD, Safiulina VF, Fattorini G, Sivakumaran S, Legname G and Cherubini E: PrPC controls via protein kinase A the direction of synaptic plasticity in the immature hippocampus. J Neurosci. 33:2973–2983. 2013. View Article : Google Scholar : PubMed/NCBI | |
Glatzel M, Abela E, Maissen M and Aguzzi A: Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med. 349:1812–1820. 2003. View Article : Google Scholar : PubMed/NCBI | |
Laurén J, Gimbel DA, Nygaard HB, Gilbert JW and Strittmatter SM: Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 457:1128–1132. 2009. View Article : Google Scholar : PubMed/NCBI | |
Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, et al: Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA. 107:2295–2300. 2010. View Article : Google Scholar : PubMed/NCBI | |
Raeber AJ, Sailer A, Hegyi I, Klein MA, Rülicke T, Fischer M, Brandner S, Aguzzi A and Weissmann C: Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci USA. 96:3987–3992. 1999. View Article : Google Scholar : PubMed/NCBI | |
Kessels HW, Nguyen LN, Nabavi S and Malinow R: The prion protein as a receptor for amyloid beta. Nature. 466:E3–E4. 2010. View Article : Google Scholar : PubMed/NCBI | |
Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA and Strittmatter SM: Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci. 30:6367–6374. 2010. View Article : Google Scholar : PubMed/NCBI | |
Benilova I and De Strooper B: Prion protein in Alzheimer's pathogenesis: A hot and controversial issue. EMBO Mol Med. 2:289–290. 2010. View Article : Google Scholar : PubMed/NCBI | |
An K, Klyubin I, Kim Y, Jung JH, Mably AJ, O'Dowd ST, Lynch T, Kanmert D, Lemere CA, Finan GM, et al: Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo. Mol Brain. 6:472013. View Article : Google Scholar : PubMed/NCBI | |
Hu NW, Nicoll AJ, Zhang D, Mably AJ, O'Malley T, Purro SA, Terry C, Collinge J, Walsh DM and Rowan MJ: mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat Commun. 5:33742014. View Article : Google Scholar : PubMed/NCBI | |
Bitel CL, Feng Y, Souayah N and Frederikse PH: Increased expression and local accumulation of the prion protein, Alzheimer Aβ peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes. BMC Physiol. 10:182010. View Article : Google Scholar : PubMed/NCBI | |
Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC and Strittmatter SM: Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci. 15:1227–1235. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sivanesan S, Tan A and Rajadas J: Pathogenesis of Abeta oligomers in synaptic failure. Curr Alzheimer Res. 10:316–323. 2013. View Article : Google Scholar : PubMed/NCBI | |
Gerlai R: Eph receptors and neural plasticity. Nat Rev Neurosci. 2:205–209. 2001. View Article : Google Scholar : PubMed/NCBI | |
Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, et al: Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature. 469:47–52. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kullander K and Klein R: Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol. 3:475–486. 2002. View Article : Google Scholar : PubMed/NCBI | |
Yamaguchi Y and Pasquale EB: Eph receptors in the adult brain. Curr Opin Neurobiol. 14:288–296. 2004. View Article : Google Scholar : PubMed/NCBI | |
Bliss TV and Collingridge GL: A synaptic model of memory: Long-term potentiation in the hippocampus. Nature. 361:31–39. 1993. View Article : Google Scholar : PubMed/NCBI | |
Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW and Greenberg ME: EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 103:945–956. 2000. View Article : Google Scholar : PubMed/NCBI | |
Drescher U: Excitation at the synapse: Eph receptors team up with NMDA receptors. Cell. 103:1005–1008. 2000. View Article : Google Scholar : PubMed/NCBI | |
Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T and Klein R: Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell. 86:35–46. 1996. View Article : Google Scholar : PubMed/NCBI | |
Birgbauer E, Cowan CA, Sretavan DW and Henkemeyer M: Kinase independent function of EphB receptors in retinal axon pathfinding to the optic disc from dorsal but not ventral retina. Development. 127:1231–1241. 2000.PubMed/NCBI | |
Cowan CA, Yokoyama N, Bianchi LM, Henkemeyer M and Fritzsch B: EphB2 guides axons at the midline and is necessary for normal vestibular function. Neuron. 26:417–430. 2000. View Article : Google Scholar : PubMed/NCBI | |
Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W and Klein R: Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13:295–306. 1999. View Article : Google Scholar : PubMed/NCBI | |
Grunwald IC, Korte M, Wolfer D, Wilkinson GA, Unsicker K, Lipp HP, Bonhoeffer T and Klein R: Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron. 32:1027–1040. 2001. View Article : Google Scholar : PubMed/NCBI | |
Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC and Pawson T: The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron. 32:1041–1056. 2001. View Article : Google Scholar : PubMed/NCBI | |
Takasu MA, Dalva MB, Zigmond RE and Greenberg ME: Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science. 295:491–495. 2002. View Article : Google Scholar : PubMed/NCBI | |
Walsh DM and Selkoe DJ: Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 44:181–193. 2004. View Article : Google Scholar : PubMed/NCBI | |
Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S and Malinow R: APP processing and synaptic function. Neuron. 37:925–937. 2003. View Article : Google Scholar : PubMed/NCBI | |
Kubagawa H, Burrows PD and Cooper MD: A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA. 94:5261–5266. 1997. View Article : Google Scholar : PubMed/NCBI | |
Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C and Tessier-Lavigne M: PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science. 322:967–970. 2008. View Article : Google Scholar : PubMed/NCBI | |
Takai T: Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology. 115:433–440. 2005. View Article : Google Scholar : PubMed/NCBI | |
Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC, Hyman BT and Shatz CJ: Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science. 341:1399–1404. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang X, Takata T, Bai X, Ou F, Yokono K and Sakurai T: Pyruvate prevents the inhibition of the long-term potentiation induced by amyloid-β through protein phosphatase 2A inactivation. J Alzheimers Dis. 30:665–673. 2012.PubMed/NCBI | |
Lehmann B, Schwab I, Böhm S, Lux A, Biburger M and Nimmerjahn F: FcγRIIB: A modulator of cell activation and humoral tolerance. Expert Rev Clin Immunol. 8:243–254. 2012. View Article : Google Scholar : PubMed/NCBI | |
Baerenwaldt A and Nimmerjahn F: Immune regulation: FcgammaRIIB - regulating the balance between protective and autoreactive immune responses. Immunol Cell Biol. 86:482–484. 2008. View Article : Google Scholar : PubMed/NCBI | |
Bolland S and Ravetch JV: Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity. 13:277–285. 2000. View Article : Google Scholar : PubMed/NCBI | |
Kam TI, Song S, Gwon Y, Park H, Yan JJ, Im I, Choi JW, Choi TY, Kim J, Song DK, et al: FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease. J Clin Invest. 123:2791–2802. 2013. View Article : Google Scholar : PubMed/NCBI | |
Fearon DT: The complement system and adaptive immunity. Semin Immunol. 10:355–361. 1998. View Article : Google Scholar : PubMed/NCBI | |
Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, et al: An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ. J Neurosci. 32:9677–9689. 2012. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Zeng J, Cen L, Chen Y, Wang X, Yao G, Wang W, Qi W and Kong K: Multiple roles of the p75 neurotrophin receptor in the nervous system. J Int Med Res. 37:281–288. 2009. View Article : Google Scholar : PubMed/NCBI | |
Roux PP, Bhakar AL, Kennedy TE and Barker PA: The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem. 276:23097–23104. 2001. View Article : Google Scholar : PubMed/NCBI | |
La Rosa LR, Matrone C, Ferraina C, Panico MB, Piccirilli S, Di Certo MG, Strimpakos G, Mercuri NB, Calissano P, D'Amelio M, et al: Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR. J Alzheimers Dis. 33:265–272. 2013.PubMed/NCBI | |
Yaar M, Zhai S, Panova I, Fine RE, Eisenhauer PB, Blusztajn JK and Lopez-Coviella I and Gilchrest BA: A cyclic peptide that binds p75(NTR) protects neurones from beta amyloid (1–40)-induced cell death. Neuropathol Appl Neurobiol. 33:533–543. 2007.PubMed/NCBI | |
Yaar M, Arble BL, Stewart KB, Qureshi NH, Kowall NW and Gilchrest BA: p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation. Cell Mol Neurobiol. 28:1027–1031. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chakravarthy B, Gaudet C, Ménard M, Atkinson T, Brown L, Laferla FM, Armato U and Whitfield J: Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice. J Alzheimers Dis. 19:915–925. 2010.PubMed/NCBI | |
Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD and Mufson EJ: Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis. 41:338–352. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zeng F, Lu JJ, Zhou XF and Wang YJ: Roles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target. Biochem Pharmacol. 82:1500–1509. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH, Sun Y, Yang M, Lim Y, Evin G, et al: p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. J Neurosci. 31:2292–2304. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zhou XF and Wang YJ: The p75NTR extracellular domain: A potential molecule regulating the solubility and removal of amyloid-β. Prion. 5:161–163. 2011. View Article : Google Scholar : PubMed/NCBI | |
Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D and Della-Bianca V: Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. J Mol Neurosci. 25:141–156. 2005. View Article : Google Scholar : PubMed/NCBI | |
Knowles JK, Rajadas J, Nguyen TV, Yang T, LeMieux MC, Griend L Vander, Ishikawa C, Massa SM, Wyss-Coray T and Longo FM: The p75 neurotrophin receptor promotes amyloid-beta(1–42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci. 29:10627–10637. 2009. View Article : Google Scholar : PubMed/NCBI | |
Frade JM and López-Sánchez N: A novel hypothesis for Alzheimer disease based on neuronal tetraploidy induced by p75 (NTR). Cell Cycle. 9:1934–1941. 2010. View Article : Google Scholar : PubMed/NCBI | |
Le Novere N and Changeux JP: Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J Mol Evol. 40:155–172. 1995. View Article : Google Scholar : PubMed/NCBI | |
Nai Q, McIntosh JM and Margiotta JF: Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function. Mol Pharmacol. 63:311–324. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hogg RC, Raggenbass M and Bertrand D: Nicotinic acetylcholine receptors: From structure to brain function. Rev Physiol Biochem Pharmacol. 147:1–46. 2003.PubMed/NCBI | |
Albuquerque EX, Pereira EF, Alkondon M and Rogers SW: Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev. 89:73–120. 2009. View Article : Google Scholar : PubMed/NCBI | |
Perry EK, Morris CM, Court JA, Cheng A, Fairbairn AF, McKeith IG, Irving D, Brown A and Perry RH: Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience. 64:385–395. 1995. View Article : Google Scholar : PubMed/NCBI | |
Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R and Dunwiddie TV: Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci. 18:1187–1195. 1998.PubMed/NCBI | |
McQuiston AR and Madison DV: Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci. 19:2887–2896. 1999.PubMed/NCBI | |
Blum S, Moore AN, Adams F and Dash PK: A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci. 19:3535–3544. 1999.PubMed/NCBI | |
Selcher JC, Atkins CM, Trzaskos JM, Paylor R and Sweatt JD: A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem. 6:478–490. 1999. View Article : Google Scholar : PubMed/NCBI | |
Schafe GE, Nadel NV, Sullivan GM, Harris A and LeDoux JE: Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem. 6:97–110. 1999.PubMed/NCBI | |
Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM and Sweatt JD: The MAPK cascade is required for mammalian associative learning. Nat Neurosci. 1:602–609. 1998. View Article : Google Scholar : PubMed/NCBI | |
Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G and Silva AJ: Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell. 79:59–68. 1994. View Article : Google Scholar : PubMed/NCBI | |
Mills J, Charest D Laurent, Lam F, Beyreuther K, Ida N, Pelech SL and Reiner PB: Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J Neurosci. 17:9415–9422. 1997.PubMed/NCBI | |
Criscuolo C, Accorroni A, Domenici L and Origlia N: Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. Neuroscience. 294:166–171. 2015. View Article : Google Scholar : PubMed/NCBI |